Kostakoglu, L. Et Al. 1997. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7 , 1009-1014.

Kostakoglu, L., Uysal, U., Ozyar, E., Hayran, M., Uzal, D., Demirkazik, F., ... Kars, A.(1997). Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7, 1009-1014.

Kostakoglu, L Et Al. "Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma," JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7, 1009-1014, 1997

Kostakoglu, L Et Al. "Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma." JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7, pp.1009-1014, 1997

Kostakoglu, L. Et Al. (1997) . "Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma." JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7, pp.1009-1014.

@article{article, author={L Kostakoglu Et Al. }, title={Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma}, journal={JOURNAL OF NUCLEAR MEDICINE}, year=1997, pages={1009-1014} }